Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sheppard R&D Consultancy is a private UK consulting company founded in 2018 that appears to provide R&D and drug discovery advisory services to biotech and investment clients rather than operating as a traditional therapeutics developer. Public information indicates the firm is active and led by founder David Sheppard, an experienced drug discovery scientist with prior work across preclinical pharmaceutical research. Available third-party and profile information links the consultancy to support for biotechnology clients including companies working in mRNA therapeutics and AI-driven drug discovery. There is no clear evidence that the company has its own clinical-stage pipeline, proprietary therapeutic assets, or marketed products. As a result, it is best characterized as a small life-science-focused consultancy serving the biotech ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sheppard R&D Consultancy.